InsidersTradesSigma
Follow the 경보제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 경보제약 has recorded 1 public disclosures. Market capitalisation: €119.8bn. The latest transaction was disclosed on 5 March 2026 (Purchase). Among the most active insiders: 정희록. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
경보제약是一家在XKRX市场上市的医疗保健和制药公司。该公司专注于创新药物的研发。